Column Group II GP, LP

CIK 1645333 · last filed 2022-05-23

Column Group II GP, LP is a corporate insider who has filed 9 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing shows the insider bought $5.3M of NGM on May 23, 2022. Across all open-market trades the lifetime net is −$182.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $93.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$93.74M

Companies

4

Total Filings

9

Lifetime Open-Market Net

-$182.12M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
NGM BIOPHARMACEUTICALS INC (NGM) Delisted	10%+ Owner	11,118,333	$1.54	$17.12M	$16.66M	2	2022-05-23
ORIC	10%+ Owner	3,855,883	$11.91	$45.92M	$0	1	2021-11-16
RAPT Therapeutics, Inc. (RAPT) Delisted	10%+ Owner	326,346	$58.01	$18.93M	-$198.78M	3	2021-08-24
RCUS	10%+ Owner	1,767,676	$27.05	$47.82M	$0	1	2018-03-19

Recent Filings

9 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2022-05-23	NGM BIOPHARMACEUTICALS INC (NGM) Delisted	Buy (P)	+397,000	$5.30M	EDGAR
2021-11-16	ORIC	Mixed	−5,049,345	$1.33M	EDGAR
2021-08-24	RAPT Therapeutics, Inc. (RAPT) Delisted	Sell (S)	−957,460	-$29.97M	EDGAR
2020-09-23	RAPT Therapeutics, Inc. (RAPT) Delisted	Sell (S)	−5,472,000	-$168.81M	EDGAR
2020-08-17	NGM BIOPHARMACEUTICALS INC (NGM) Delisted	Buy (P)	+643,130	$11.35M	EDGAR
2020-06-22	RAPT Therapeutics, Inc. (RAPT) Delisted	Other (J)	—	$0	EDGAR
2019-04-02	—	U	−59,786,478	-$349.75M
2018-03-19	RCUS	Conv (C)	+24,785,950	$0	EDGAR
2016-09-22	—	Buy (P)	+4,000,000	$25.00M

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.